Fake Medicines For Cancer Patients Seized, 3 Arrested

New Delhi : A consignment of spurious medication meant for the treatment of cancer patients was seized from three people in southeast Delhi’s Jasola Vihar. Sources said police are probing whether the counterfeit medication was produced in another country.

Police said they received information about the three people who allegedly sold fake medication to the kin of cancer patients at high prices. The informant told the cops on Wednesday morning that the three would visit Jasola Vihar. “A trap was laid and a team caught the trio,” sources said.

The cops seized more than 100 packets of fake medicines from the three accused. “One of the packets had a label stating it was manufactured in Bangladesh. We are probing this,” sources said.

On being asked to produce documentation for carrying the medicines, the trio had no answers. “They were not carrying any documents or medical slips,” the officer said.

Police seized 73 packets of drugs labelled as Palbocent and Lenvanix — medication used to treat cancer — from one of the men. “We also seized medicines labelled as Osicent, Crizocent, Ibrucent from the other two,” said a police officer.

The medicines were checked by drug inspectors, who declared them as doubt quality. The trio was taken to the police station for further questioning. Sources said they are probing their links in other states and also how many, people were duped by them.

It is not the first time Delhi Police has caught people with fake medicines. In June this year, police arrested 10 people, including two doctors, and busted a unit manufacturing fake life-saving drugs meant to treat Covid-19 patients. In May, cops arrested two people who were cheating Covid patients by selling fake Remdesivir at exorbitant rates.

  • Related Posts

    WHO launches new primary health care course to strengthen health systems globally

    Health is a human right – yet not everyone can access the health services they need, when and where they need them, without financial hardship. Primary health care (PHC) provides…

    Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

    Bengaluru: The Central Council for Research in Ayurvedic Sciences (CCRAS) has called for stronger scientific evidence, safety monitoring and translation of research into market-ready technologies to improve the credibility and…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    WHO launches new primary health care course to strengthen health systems globally

    WHO launches new primary health care course to strengthen health systems globally

    Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

    Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert